Member Info for Adastra

I also expect weekend press comment from previously positive tipsters in the Mail and Times to resurface this week heralding a long overdue rerate.

Easing of lockdown also opens the doors to a huge volume of mandatory pressurised equipment testing that Pres is qualified to do and has to be done for customers on site and in situ. The backlog here must be substantial for Pressure Techs qualified inspectors. Plus oil and gas markets as well as hydrogen are opening up quickly.

Not without its interests to larger players like IMI either.

The early receipt of the promissory note for £3.1m plus £0.4m interest plus receipt of the previously announced deferral of revenue on a defence contract from Q4 FY20 into Q1 FY21 should help interim progress as lockdown drops.

Looks like you're correct....confusing but have been watching for long time. My main reason was the payments due last year that will have been paid into current year telegraphed in finals. Onward and upward from here

Lots of positive info out there if you go trawling.
DYR and benefit.

I did the research but missed the low. I'm in. This is a selection of news items I gleaned over the weekend from Pres twitter, feed and Glossop/Buxton news.
Pressure tech
Next month we look forward to announcing the results of all our hard work and efforts with some very exciting news, and hopefully, some better weather!"
Pressure Tech in Hadfield has seen a 50 per cent increase in orders this year, which has presented its own challenges
The visit also provided the opportunity for the MP to see Pressure Tech’s success in the Green Hydrogen Fuel Cell market, with a recent order secured for 2,000 pressure regulators being exported to a key customer in the USA.  
A recent contract win from the USA means the company needs to effectively double its production capacity, and Steve hopes to land two or three accounts with similar scope.

Managing director, Steve Yorke-Robinson explains: "Norway is absolutely a market of interest to us. Several of the world’s leading OEMs for Hydraulic Power Units (HPUs), Intervention Workover Control Systems (IWOCs) and Chemical Injection Systems are located in Norway, and these applications are key targets for our hydraulic pressure regulators in particular. In addition, Norway is a leader in subsea technology, so we expect the demand for our subsea pressure regulators to increase over the coming years and decades."
Pressure Tech's financial year started in November, so the end of April marked the half way point.

We are pleased to announce that we have made a fantastic start, with a 65% increase in sales order intake compared to last year!

It also marks a record order entry for the first 6 months in any of our previous 20+ years!
Do with it as you will.

........and that Naked Trader gave reasoned arguments for investment on two purchases at 5.35 and 5.95p with a current target of 10p. He currently holds 250k so interesting diversity of opinion. My gut feeling is for an 'all will be revealed' finals bonanza on the 14th as deals are signed and value surfaces.

Also worth noting that the now divested Hunt Thermal TPG heavy engineering business was haemorraging £1.6m on £6.9m turnover in 2019. That should translate to a whopping bottom-line boost in the current year.

Stockopedia is showing results due 10th June. Don't know how info obtained but at least it's showing next week. Think a lot will be resolved and share price should bounce nicely from here as it's 20% below last fundraise, is debt free and has a lot of positives in the mix. I've reinvested a punt amount at this level expecting a very decent short term return on 5.33p paid. Interestingly undervalued imo given t/o versus MCap.

The inflection point that will rerate GSK is close. The shingles vaccine has huge earnings potential for turnover and profit as does the transformational investment in Curevac but investors seem to be focussing on Elliott. Not that relevant in the bigger picture that is unfolding. Clarity on the GSK split this month should accelerate the rerate.

SC are now almost out; bear in mind that these sales are being taken up quickly hence the see-saw. Once the flow stops then the gap jump to 30+
Just a matter of time and that is rapidly decreasing with results in 2 weeks and announcement that company is debt-free. Once that happens we are talking $800/oz hitting the bottom line.....sweet.

There's only so many times it can bounce along the bottom when the fundamentals are all rising. Once the known seller has cleared (which is imminent), the disparity between current MCap and recent soaring gold price will fall away quickly and this will/must gap-jumps to reflect reality. The proximity of results announcement in 2 weeks (June 3rd last year) also provides a springboard as all debt should have been cleared throwing profits straight to the bottom line. Solid.

Great opportunity to get on board as HUM is only a fortnight away from results. Good positive last t/u gave indication of sound progress.
"Our balance sheet continued to strengthen during the quarter. Our net cash position improved, with the last remaining Company debt of ~US$4.6 million forecast to be paid this quarter, taking the Company into a debt free position, as we forecast over 12 months ago, being a noteworthy achievement" Gold price working strongly in company favour. Not without some risk but diverse and cash flow increasing. Solid.

Look at revenue growth which almost doubled in each of the years pre-covid £31m, £54m, £98m. Steady covid year with a big upswing expected this year all being well as restrictions ease. Solid management and tight financial measures should give healthy bottom line. Current MCap equals NAV so downside is pretty well bulletproof given last upbeat t/u in April. That gave a nice bounce in the share price which has pulled back enough to make investment here look a shrewd move now.

Personally I think the effect of inflation on the work carried out by Ince is minimal compared to the huge upswing in business which should be heading in their direction as the brakes come off covid lockdown. Ince is primarily active in commercial and maritime law plus high net worth individuals, all of which should grow strongly as the economy restarts.

It's looking very probable that we'll see an earnings upgrade as lockdown eases as the business had already indicated increased momentum in it's last positive t/u. Good to see a company where all directors AND staff have skin in the game.

Ince has fallen back since it's strong trading update on April 22nd providing an excellent top up opportunity. Naked trader bought in at 75p looking for a 95p target. Ince had a deeply discounted rights issue in January 2020 with all directors and staff buying in at 45p. It's still only risen back to the current level with plenty of legs to get back to pre-rights £1 and well beyond. Directors are keen to reinstitute divi on the back of strong trading. Plus the expected rise in legal cases as furlough ends should really accelerate UK growth. Good company, strong management and trading at NAV. Solid.

Just been asked., when does Hfx pay Aviva divi into acct?

And up we go....
Downtrend broken
Rerate underway
Just piled in